Cit­ing sig­nif­i­cant progress on a cure for di­a­betes, No­vo Nordisk beefs up its stem cell pipeline with new col­lab­o­ra­tions

A grow­ing group of biotech star­tups look­ing to ad­vance a line­up of po­ten­tial stem cell cures for Type 1 di­a­betes can look to a big …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.